Global Vascular Access Devices Market Expected to Grow to Nearly $15 Billion by 2030; Becton Dickinson and 3M Dominate the Market
The global vascular access device market reached a value of $12.5 billion in 2023 and is [...]
Montrose Regional Health Joins Guardian Research Network’s Nationwide Healthcare Research Consortium
Guardian Research Network (GRN) has announced that Montrose Regional Health (MRH), a critical healthcare facility in [...]
Evidation Announces Major Partnership with ‘Our Future Health’ for Multi-Year UK Health Research Program
Evidation, a health-tech company, has announced a significant partnership with Our Future Health, a national health [...]
Reagan-Udall Foundation Calls for Overhaul of Post-Market Evidence Generation System, Suggests FDA-Led Approach
The Reagan-Udall Foundation asserts in a new report that the current post-market evidence generation system is [...]
EMD Serono to Relocate Headquarters to Boston’s Seaport District, Embracing Hybrid Work and Collaboration
EMD Serono, the US pharma subsidiary of Merck KGaA, is set to move its headquarters to [...]
NIH’s New Director Monica Bertagnolli Concerned about Obesity; Emphasizes the Importance of Clinical Trials and Role of Insurers in Healthcare Research
Newly appointed NIH director Monica Bertagnolli expressed her concern about obesity and highlighted the importance of [...]
Real-World Data Empowers Pharma Advertising: An Interview with PurpleLab CEO Mark Brosso
In a conversation with Mark Brosso, the CEO of PurpleLab, it was uncovered that the pharmaceutical [...]
U.S. Men’s Life Expectancy Gap Widens to Largest Since 1996 Amid Public Health Crises and Covid-19 Impact
The life expectancy of men in the U.S. is about six years shorter than women, according [...]
Changes in Health Insurance Cost Estimation Could Boost US Inflation Measures
Starting with the October consumer price index, the Bureau of Labor Statistics (BLS) is changing how [...]
Novo Nordisk Invests $6 Billion in API Production Expansion to Meet High Demand
Novo Nordisk is investing over $6 billion to expand Denmark's active pharmaceutical ingredients (API) production capacity. [...]
FDA Approves Takeda’s Novel, Chemotherapy-Free Pill Fruzaqla for Metastatic Colorectal Cancer
The FDA approved Takeda’s Fruzaqla, a pill treatment for refractory metastatic colorectal cancer (mCRC), making it [...]
AstraZeneca Acquires Obesity Drug Developer Eccogene’s ECC5004 for $185 Million, Aiming at Type 2 Diabetes and Obesity Markets
AstraZeneca is acquiring obesity drug developer Eccogene's ECC5004 for $185 million with the potential to pay [...]
Eli Lilly to Release Weight Loss Drug Zepbound at a Discount, Poised for Fierce Competition with Novo Nordisk’s Wegovy
Eli Lilly's weight loss drug Zepbound is set to compete with Novo Nordisk's Wegovy. Zepbound, approved [...]
Eli Lilly’s Tirzepatide Receives FDA Approval for Obesity Treatment Under Brand Zepbound
Eli Lilly’s drug tirzepatide, branded as Mounjaro for type 2 diabetes, has gained FDA approval to [...]
Biogen Q3 Financials: Stable Revenues, Regulatory Success with Leqembi and Zurzuvae Amid Earnings Dip
Biogen has updated its financial outlook, indicating mixed results in its recent quarterly report. The company [...]
Long-lasting Impact of Childhood Gun Injuries on Survivors and Families and the Importance of Gun Safety Promotion
Firearms have been the leading cause of death among children and teens in the U.S. since [...]
Vertex Pharmaceuticals Misses Q3 Sales Estimates Due to Weak Demand for Older CF Treatments
Vertex Pharmaceuticals missed Wall Street estimates for Q3 sales, primarily due to weaker demand for older [...]
Navigating the Challenges of Real-World Data Management for Improving Patient Outcomes
Real-world data (RWD) and real-world evidence (RWE) can improve patient outcomes by optimizing clinical trials and [...]
Izervay’s Efficacy Increases Over Time, Outpacing Competitor in Treating Geographic Atrophy: 2-Year GATHER2 Study Finds
Astellas' drug Izervay, a treatment for eye condition geographic atrophy, has demonstrated an increase in efficacy [...]
ASN Kidney Week 2023: Studies Highlight Issues in CKD Diagnosis Delays and Management Using Real-World Data
Two posters presented at ASN Kidney Week 2023 analyzed real-world data on Chronic Kidney Disease (CKD) [...]
Medicaid Disenrollment: Procedural Issues Leave 10 Million People Without Coverage, Children Majorly Affected
Over the past six months, 10 million people have been disenrolled from Medicaid, according to a [...]
Transformative Role of Artificial Intelligence in Healthcare: Enhancing Patient Care, Clinical Research, Supply Chain Resiliency and Workforce Optimization
Artificial intelligence (AI) is transforming the healthcare industry in impactful ways. AI enables higher-quality patient care [...]
Robust Quarterly Earnings seen for Eli Lilly, Novo Nordisk, Moderna, and Regeneron Amid Success of Key Drugs
Eli Lilly, Novo Nordisk, Moderna, and Regeneron posted solid quarterly earnings due to the success of [...]
Updated ACS Lung Cancer Screening Guidelines: Redefining High-Risk Criteria, Expanding Age Range, and Easing Smoking History Requirements
The American Cancer Society (ACS) has updated its recommendations for lung cancer screening, dropping the criterion [...]
FDA Approves Novartis’ Cosentyx as First New Biologic HS Treatment in Decade: A Potential Rival for AbbVie’s Humira
The U.S. FDA has approved Novartis' Cosentyx (secukinumab) for treating moderate to severe hidradenitis suppurativa (HS), [...]
